Tower Research Capital LLC (Trc) Compugen LTD Transaction History

Tower Research Capital LLC (Trc)

$4.87 Billion
Q4 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Compugen LTD stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 10,740 shares of CGEN stock, worth $23,520. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,740

Previous 11,931 9.98%

Holding current value

$23,520

Previous $21,000 23.81%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$1.41 - $1.93 $1,679 - $2,298	-1,191 Reduced 9.98%	10,740 $16,000
Q3 2024 Nov 14, 2024	BUY	$1.56 - $2.1 $18,612 - $25,055	11,931 New	11,931 $21,000
Q4 2023 Feb 13, 2024	BUY	$0.53 - $2.0 $1,650 - $6,228	3,114 New	3,114 $6,000
Q2 2023 Aug 14, 2023	BUY	$0.57 - $1.38 $464 - $1,124	815 Added 440.54%	1,000 $1,000
Q1 2023 May 09, 2023	SELL	$0.68 - $1.11 $8,650 - $14,121	-12,722 Reduced 98.57%	185 $0
Q4 2022 Feb 10, 2023	SELL	$0.58 - $1.2 $12,193 - $25,228	-21,024 Reduced 61.96%	12,907 $9,000
Q3 2022 Nov 10, 2022	BUY	$0.66 - $2.32 $21,693 - $76,256	32,869 Added 3095.01%	33,931 $22,000
Q2 2022 Aug 15, 2022	SELL	$1.57 - $3.33 $12,908 - $27,379	-8,222 Reduced 88.56%	1,062 $2,000
Q1 2022 May 12, 2022	BUY	$2.76 - $4.64 $18,574 - $31,227	6,730 Added 263.51%	9,284 $30,000
Q4 2021 Feb 14, 2022	SELL	$4.09 - $7.16 $50,679 - $88,719	-12,391 Reduced 82.91%	2,554 $11,000
Q3 2021 Nov 15, 2021	BUY	$5.8 - $8.02 $86,072 - $119,016	14,840 Added 14133.33%	14,945 $89,000
Q2 2021 Aug 16, 2021	SELL	$6.87 - $9.16 $427,526 - $570,035	-62,231 Reduced 99.83%	105 $1,000
Q1 2021 May 17, 2021	BUY	$7.67 - $13.77 $445,887 - $800,505	58,134 Added 1383.48%	62,336 $536,000
Q4 2020 Feb 16, 2021	SELL	$12.07 - $17.95 $50,162 - $74,600	-4,156 Reduced 49.72%	4,202 $51,000
Q3 2020 Nov 16, 2020	BUY	$14.16 - $19.45 $86,545 - $118,878	6,112 Added 272.13%	8,358 $135,000
Q2 2020 Aug 13, 2020	BUY	$6.97 - $17.12 $15,654 - $38,451	2,246 New	2,246 $34,000
Q1 2020 May 15, 2020	SELL	$5.79 - $11.83 $31,074 - $63,491	-5,367 Closed	0 $0
Q4 2019 Feb 07, 2020	BUY	$3.9 - $6.16 $20,931 - $33,060	5,367 New	5,367 $32,000
Q4 2018 Feb 14, 2019	SELL	$2.17 - $3.8 $3,252 - $5,696	-1,499 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$3.0 - $4.05 $2,628 - $3,547	-876 Reduced 36.88%	1,499 $6,000
Q2 2018 Aug 15, 2018	SELL	$3.15 - $4.7 $11,380 - $16,981	-3,613 Reduced 60.34%	2,375 $8,000
Q1 2018 May 15, 2018	BUY	$2.5 - $4.45 $11,865 - $21,119	4,746 Added 382.13%	5,988 $27,000
Q4 2017 Feb 09, 2018	BUY	$2.35 - $4.0 $2,918 - $4,968	1,242	1,242 $3,000

Others Institutions Holding CGEN

# of Institutions

Shares Held

13.1M

Call Options Held

29.7K

Put Options Held

12.7K

View Full List

About COMPUGEN LTD

Ticker CGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,624,600
Market Cap $190M
Description
Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...

More about CGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Compugen LTD Transaction History